美股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

再鼎医药

29.71

+0.87003.02%

盘后：29.30-0.4100-1.38%16:09 EDT

成交量：69.61万

成交额：2,048.91万

市值：32.57亿

市盈率：-11.43

高：29.91

开：28.64

低：28.63

收：28.84

数据加载中...

总览公司新闻公告

异动解读 | 花旗高盛看好未来两年催化剂再鼎医药盘中大涨5%

再鼎医药盘中异动快速拉升5.04%

中金：维持再鼎医药“跑赢大市”评级升目标价至34.41港元

美股异动｜再鼎医药盘前涨超3% 绩后获多家大行上调目标价

港股那点事

【中金升再鼎医药目标价至34.41港元】中金升再鼎医药目标价至34.41港元，今年指引反映增长较高。

中金升再鼎医药目标价至34.41港元今年指引反映增长较高

中金：维持再鼎医药(09688)“跑赢大市”评级升目标价至34.41港元

研报掘金｜中金：上调再鼎医药H股目标价至34.41港元指今明两年有大量催化剂

研报掘金｜中金：上调再鼎医药H股目标价至34.41港元指今明两年有大量催化剂

格隆汇资讯

异动解读 | 再鼎医药盘中大跌5.48%,分析师下调评级目标价或是主因

再鼎医药盘中异动早盘急速下挫5.05%

B of A Securities：下调再鼎医药(ZLAB.US)评级，由买入调整至中性评级, 目标价由29.00美元调整至36.10美元。

【再鼎医药：repotrectinib在台湾地区获批双适应证】3月3日，再鼎医药宣布，中国台湾地区药品审评机构已批准repotrectinib的新药上市申请，用于治疗：ROS1阳性之局部晚期或转移性非小细胞肺癌的成人患者，NTRK基因融合阳性之实体肿瘤的成人患者。

再鼎医药宣布repotrectinib在台湾地区获批双适应证

再鼎医药：25 年或成里程碑，评级买入

【券商聚焦】浦银国际维持再鼎医药(09688)“买入”评级指其4Q24收入大致符合预期经营亏损略好于预期

再鼎医药盘中异动早盘急速跳水5.21%

异动解读 | 再鼎医药盘前飙涨5.5%,原因是公司2024财年收入及新品获重大进展

再鼎医药公布2024年第四季度及全年财务业绩和近期公司进展

再鼎医药2024年年报：经营亏损降至2.82亿美元同比下降23%

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/ZLAB/news?page=4"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ZLAB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ZLAB\",,,,,undefined,":{"symbol":"ZLAB","market":"US","secType":"STK","nameCN":"再鼎医药","latestPrice":29.71,"timestamp":1745265600000,"preClose":28.84,"halted":0,"volume":696117,"hourTrading":{"tag":"盘后","latestPrice":29.3,"preClose":29.71,"latestTime":"16:09 EDT","volume":3043,"amount":90406.70839,"timestamp":1745266158942},"delay":0,"floatShares":100222282,"shares":109637154,"eps":-2.59837,"marketStatus":"盘后交易","change":0.87,"latestTime":"04-21 18:18:20 EDT","open":28.64,"high":29.91,"low":28.631,"amount":20489113.467933,"amplitude":0.044348,"askPrice":31.6,"askSize":40,"bidPrice":28.8,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-2.59837,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1745280000000},"marketStatusCode":4,"adr":1,"adrRate":10,"listingDate":1505880000000,"exchange":"NASDAQ","adjPreClose":28.84,"postHourTrading":{"tag":"盘后","latestPrice":29.3,"preClose":29.71,"latestTime":"16:09 EDT","volume":3043,"amount":90406.70839,"timestamp":1745266158942},"volumeRatio":0.387328,"impliedVol":0.4254,"impliedVolPercentile":0.172},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ZLAB\",,,,,undefined,":{"symbol":"ZLAB","floatShares":100222282,"roa":"-15.87%","roe":"-31.41%","lyrEps":-2.59837,"volumeRatio":0.387328,"shares":109637154,"dividePrice":0,"high":29.91,"amplitude":0.044348,"preClose":28.84,"low":28.631,"week52Low":13.48,"pbRate":"3.87","psRate":"8.16","week52High":39.77,"institutionHeld":0,"latestPrice":29.71,"committee":0.428571,"eps":-2.59837,"divideRate":0,"volume":696117,"delay":0,"ttmEps":-2.59837,"open":28.64,"prevYearClose":26.19,"prevWeekClose":28.84,"prevMonthClose":36.14,"prevQuarterClose":36.14,"fiveDayClose":29.54,"twentyDayClose":35.09,"sixtyDayClose":25.64,"earningDate":1746633600000,"earningTime":"盘前"},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ZLAB\",pageSize:20,pageCount:4,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1168191430","title":"异动解读 | 花旗高盛看好未来两年催化剂 再鼎医药盘中大涨5%","url":"https://stock-news.laohu8.com/highlight/detail?id=1168191430","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1168191430?lang=zh_cn&edition=fundamental","pubTime":"2025-03-04 22:40","pubTimestamp":1741099241,"startTime":"0","endTime":"0","summary":"再鼎医药今日盘中大涨5%,主要受多家投行看好该股未来发展前景所推动。中金发布研报称,维持再鼎医药\"跑赢大市\"评级,并将目标价上调22.5%至34.41港元。花旗将再鼎医药目标价轻微上调至71美元,给予\"买入\"评级。该行认为,今年渠道数据、Vygart的增长,以及2026年KarXT获准上市的前景,将重新激发投资者对该股的热情。高盛也将再鼎医药目标价上调至42.01港元,重申2025年是该公司的发展里程碑年。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ZLAB"],"gpt_icon":0},{"id":"2516775746","title":"再鼎医药盘中异动 快速拉升5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516775746","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516775746?lang=zh_cn&edition=fundamental","pubTime":"2025-03-04 22:39","pubTimestamp":1741099157,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时39分，再鼎医药股票出现异动，股价大幅上涨5.04%。再鼎医药股票所在的生物技术行业中，整体涨幅为0.12%。】高盛发表研究报告指出，再鼎医药 2024 年第四季收入按年增长 66%至 1.085 亿美元，符合该行预期的 1.08 亿美元，各项产品收入表现均符合预测。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223917989bae72&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223917989bae72&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4531","BK4585","BK4139","ZLAB","BK4548","BK4588","BK4526"],"gpt_icon":0},{"id":"2516628250","title":"中金：维持再鼎医药“跑赢大市”评级 升目标价至34.41港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516628250","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516628250?lang=zh_cn&edition=fundamental","pubTime":"2025-03-04 17:26","pubTimestamp":1741080360,"startTime":"0","endTime":"0","summary":"　　中金发布研报称，维持再鼎医药“跑赢大市”评级，将港股目标价上调22.5%至34.41港元。再鼎医药去年业绩稍微胜过该行预期，主要得益于艾加莫德收入高企。公司为今年表现提供指引，收入达5.6亿美元至5.9亿美元，目标非通用会计准则经营盈利在今年第四季收支平衡，超该行预期。　　中金指，留意到公司在今明两年有大量的催化剂，料今年上半年会就ZL-1310公布更多数据，另预期会在上半年就Bemarituzumab递交内地上市申请。至于KarXT，该行料在明年开始商业化。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/tob/2025-03-04/doc-inennutp2729281.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["ZLAB","09688"],"gpt_icon":0},{"id":"2516562822","title":"美股异动｜再鼎医药盘前涨超3% 绩后获多家大行上调目标价","url":"https://stock-news.laohu8.com/highlight/detail?id=2516562822","media":"港股那点事","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516562822?lang=zh_cn&edition=fundamental","pubTime":"2025-03-04 17:15","pubTimestamp":1741079700,"startTime":"0","endTime":"0","summary":"格隆汇3月4日｜再鼎医药盘前涨超3%，报32.7美元。花旗将再鼎医药美股目标价由70美元轻微上调至71美元，给予“买入”评级，相信今年的渠道数据、Vygart增长、越来越接近2026年KarXT推出的前景，应能重新激发投资者对该股的情绪。高盛将再鼎医药H股目标价从40.4港元上调至42.01港元，给予“买入”评级，重申2025年是再鼎医药发展里程碑年。中金将再鼎医药H股目标价上调22.5%至34.41港元，维持“跑赢大市”评级，留意到公司在今明两年有大量的催化剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/bxjj/2025-03-04/doc-inennutp2725362.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["ZLAB","09688"],"gpt_icon":0},{"id":"2516949645","title":"【中金升再鼎医药目标价至34.41港元】中金升再鼎医药目标价至34.41港元，今年指引反映增长较高。","url":"https://stock-news.laohu8.com/highlight/detail?id=2516949645","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516949645?lang=zh_cn&edition=fundamental","pubTime":"2025-03-04 15:26","pubTimestamp":1741073216,"startTime":"0","endTime":"0","summary":"中金升再鼎医药目标价至34.41港元，今年指引反映增长较高。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/04152648506190.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["ZLAB","09688"],"gpt_icon":0},{"id":"2516164536","title":"中金升再鼎医药目标价至34.41港元 今年指引反映增长较高","url":"https://stock-news.laohu8.com/highlight/detail?id=2516164536","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516164536?lang=zh_cn&edition=fundamental","pubTime":"2025-03-04 15:25","pubTimestamp":1741073127,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["ZLAB","07226","BK4585","BK4139","HSTECH","09688","BK4588","BK4548","BK4526","LU2488822045.USD","BK1588","YANG","BK1574","HSCEI","BK1161","BK4531"],"gpt_icon":0},{"id":"2516645574","title":"中金：维持再鼎医药(09688)“跑赢大市”评级 升目标价至34.41港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516645574","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516645574?lang=zh_cn&edition=fundamental","pubTime":"2025-03-04 15:10","pubTimestamp":1741072232,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，中金发布研报称，维持再鼎医药(09688)“跑赢大市”评级，将港股目标价上调22.5%至34.41港元。再鼎医药去年业绩稍微胜过该行预期，主要得益于艾加莫德(Efgartigimod)收入高企。公司为今年表现提供指引，收入达5.6亿美元至5.9亿美元，目标非通用会计准则经营盈利在今年第四季收支平衡，超该行预期。中金指，留意到公司在今明两年有大量的催化剂，料今年上半年会就ZL-1310公布更多数据，另预期会在上半年就Bemarituzumab递交内地上市申请。至于KarXT，该行料在明年开始商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1257418.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["ZLAB","09688"],"gpt_icon":0},{"id":"2516351645","title":"研报掘金｜中金：上调再鼎医药H股目标价至34.41港元 指今明两年有大量催化剂","url":"https://stock-news.laohu8.com/highlight/detail?id=2516351645","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516351645?lang=zh_cn&edition=fundamental","pubTime":"2025-03-04 15:07","pubTimestamp":1741072026,"startTime":"0","endTime":"0","summary":"中金发表研究报告指，再鼎医药去年业绩稍微胜过该行预期，主要得益于艾加莫德收入高企。公司为今年表现提供指引，收入达5.6亿美元至5.9亿美元，目标非通用会计准则经营盈利在今年第四季收支平衡，超该行预期。中金指，留意到公司在今明两年有大量的催化剂，料今年上半年会就ZL-1310公布更多数据，另预期会在上半年就Bemarituzumab递交内地上市申请。至于KarXT，该行料在明年开始商业化。该行上调再鼎医药H股目标价22.5%至34.41港元，维持“跑赢大市”评级。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503041511459638ba56&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503041511459638ba56&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ZLAB"],"gpt_icon":0},{"id":"2516648844","title":"研报掘金｜中金：上调再鼎医药H股目标价至34.41港元 指今明两年有大量催化剂","url":"https://stock-news.laohu8.com/highlight/detail?id=2516648844","media":"格隆汇资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516648844?lang=zh_cn&edition=fundamental","pubTime":"2025-03-04 14:49","pubTimestamp":1741070982,"startTime":"0","endTime":"0","summary":"中金发表研究报告指，再鼎医药去年业绩稍微胜过该行预期，主要得益于艾加莫德(Efgartigimod)收入高企。公司为今年表现提供指引，收入达5.6亿美元至5.9亿美元，目标非通用会计准则经营盈利在今年第四季收支平衡，超该行预期。中金指，留意到公司在今明两年有大量的催化剂，料今年上半年会就ZL-1310公布更多数据，另预期会在上半年就Bemarituzumab递交内地上市申请。至于KarXT，该行料在明年开始商业化。该行上调再鼎医药H股目标价22.5%至34.41港元，维持“跑赢大市”评级。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304144949989b1987&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304144949989b1987&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09688","ZLAB"],"gpt_icon":0},{"id":"1195942706","title":"异动解读 | 再鼎医药盘中大跌5.48%,分析师下调评级目标价或是主因","url":"https://stock-news.laohu8.com/highlight/detail?id=1195942706","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1195942706?lang=zh_cn&edition=fundamental","pubTime":"2025-03-03 22:38","pubTimestamp":1741012712,"startTime":"0","endTime":"0","summary":"再鼎医药(ZLAB)今日盘中大跌5.48%,引发市场广泛关注。公司在业务方面获得新利好,即其一款药品repotrectinib在台湾地区获批上市。但分析师下调对公司的评级和目标价或是导致股价下跌的主因。\n\n具体来说,美银美林证券下调了再鼎医药的评级,由之前的\"买入\"调整为\"中性\",同时下调了公司目标价格,由之前的29美元调整至36.10美元。这引发了市场对公司发展前景的担忧,令股价承压。\n\n对于分析师下调评级和目标价的具体原因,目前公司尚未作出回应。投资者期待公司能尽快解释清楚,并重申公司的发展方向和目标,以重拾市场信心。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"异动解读 | 再鼎医药盘中大跌5.48%,分析师下调评级目标价或是主因","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ZLAB"],"gpt_icon":0},{"id":"2516663471","title":"再鼎医药盘中异动 早盘急速下挫5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516663471","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516663471?lang=zh_cn&edition=fundamental","pubTime":"2025-03-03 22:33","pubTimestamp":1741012439,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日22时33分，再鼎医药股票出现波动，股价大幅跳水5.05%。再鼎医药股票所在的生物技术行业中，整体涨幅为0.21%。】高盛发表研究报告指出，再鼎医药 2024 年第四季收入按年增长 66%至 1.085 亿美元，符合该行预期的 1.08 亿美元，各项产品收入表现均符合预测。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503032234009637ace2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503032234009637ace2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4531","BK4548","BK4585","BK4139","ZLAB","BK4588","BK4526"],"gpt_icon":0},{"id":"2516635585","title":"B of A Securities：下调再鼎医药(ZLAB.US)评级，由买入调整至中性评级, 目标价由29.00美元调整至36.10美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2516635585","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516635585?lang=zh_cn&edition=fundamental","pubTime":"2025-03-03 21:14","pubTimestamp":1741007647,"startTime":"0","endTime":"0","summary":"B of A Securities：下调再鼎医药(ZLAB.US)评级，由买入调整至中性评级, 目标价由29.00美元调整至36.10美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/03211448492986.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["ZLAB","09688"],"gpt_icon":0},{"id":"2516021682","title":"【再鼎医药：repotrectinib在台湾地区获批双适应证】3月3日，再鼎医药宣布，中国台湾地区药品审评机构已批准repotrectinib的新药上市申请，用于治疗：ROS1阳性之局部晚期或转移性非小细胞肺癌的成人患者，NTRK基因融合阳性之实体肿瘤的成人患者。","url":"https://stock-news.laohu8.com/highlight/detail?id=2516021682","media":"金融界","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516021682?lang=zh_cn&edition=fundamental","pubTime":"2025-03-03 19:47","pubTimestamp":1741002459,"startTime":"0","endTime":"0","summary":"3月3日，再鼎医药宣布，中国台湾地区药品审评机构已批准repotrectinib的新药上市申请，用于治疗：ROS1阳性之局部晚期或转移性非小细胞肺癌的成人患者，NTRK基因融合阳性之实体肿瘤的成人患者。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/03194748491689.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1161","BK4526","09688","LU2488822045.USD","BK4139","BK1588","BK4585","BK1574","ZLAB","BK4531","BK4588","BK4548"],"gpt_icon":0},{"id":"2516639721","title":"再鼎医药宣布repotrectinib在台湾地区获批双适应证","url":"https://stock-news.laohu8.com/highlight/detail?id=2516639721","media":"美通社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516639721?lang=zh_cn&edition=fundamental","pubTime":"2025-03-03 19:45","pubTimestamp":1741002300,"startTime":"0","endTime":"0","summary":"上海和美国马萨诸塞州剑桥2025年3月3日 /美通社/ -- 再鼎医药今日宣布，中国台湾地区药品审评机构已批准repotrectinib的新药上市申请，用于治疗：  ROS1阳性之局部晚期或转移性非小细胞肺癌的成人患者 NTRK基因融合阳性之实体肿瘤的成人患者  Repotrectinib是靶向作用于ROS1和NTRK致癌因子的新一代酪氨酸激酶抑制剂。关于再鼎医药 再鼎医药是一家以研发为基础、处于商业化阶段的创新型生物制药公司，总部位于中国和美国。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4631454_ZH31454_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["BK4531","BK4548","BK4585","BK4139","LU2488822045.USD","ZLAB","BK1161","BK4588","BK4526","BK1588","09688","BK1574"],"gpt_icon":0},{"id":"2516506991","title":"再鼎医药：25 年或成里程碑，评级买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2516506991","media":"和讯网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516506991?lang=zh_cn&edition=fundamental","pubTime":"2025-03-03 15:30","pubTimestamp":1740987045,"startTime":"0","endTime":"0","summary":"【3 月 3 日，高盛称再鼎医药 2024 年第四季销售表现符合预期！】高盛发表研究报告指出，再鼎医药 2024 年第四季收入按年增长 66%至 1.085 亿美元，符合该行预期的 1.08 亿美元，各项产品收入表现均符合预测。该行认为，公司去年优化商业团队的短期影响已消散，预测 2025 财年艾加莫德收入将达 10 亿元。该行重申 2025 年是再鼎医药发展里程碑年，亏损预期持续收窄，预计今年第四季可实现盈利，关注 bemarituzumab、TIVDAK 及 Optune 等产品的新药上市申请进展，并给予“买入”评级，H 股目标价从 40.4 港元上调至 42.01 港元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025030315355698998ab9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025030315355698998ab9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09688","ZLAB"],"gpt_icon":0},{"id":"2516577628","title":"【券商聚焦】浦银国际维持再鼎医药(09688)“买入”评级 指其4Q24收入大致符合预期 经营亏损略好于预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2516577628","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516577628?lang=zh_cn&edition=fundamental","pubTime":"2025-03-03 14:12","pubTimestamp":1740982325,"startTime":"0","endTime":"0","summary":"金吾财讯 | 浦银国际发研报指，再鼎医药 4Q24收入大致符合预期，经营亏损略好于预期：4Q24公司实现1.085亿美元产品净收入，大致符合VisibleAlpha一致预期和该行预期，核心产品艾加莫德略超预期，其他现有产品环比较为稳定；净亏损8,168万美元，高于VA预期和该行预期，主要受到2,342万美元汇兑损失影响。该行微调了2025E净亏损和2026E净盈利，主要由于轻微上调2025E、2026E艾加莫德收入预测及轻微上调销售行政费用预测。","market":"nz","thumbnail":"https://static.szfiu.com/news/20250106/NGZhNmEwMzJkNDhkNWE0NjE0NjM0MTA4NTA5NzI5NDQz.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250106/NGZhNmEwMzJkNDhkNWE0NjE0NjM0MTA4NTA5NzI5NDQz.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1954217","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZLAB","09688"],"gpt_icon":0},{"id":"2514378655","title":"再鼎医药盘中异动 早盘急速跳水5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514378655","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514378655?lang=zh_cn&edition=fundamental","pubTime":"2025-02-28 22:30","pubTimestamp":1740753024,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日22时30分，再鼎医药股票出现波动，股价急速下跌5.21%。截至发稿，该股报32.59美元/股，成交量5180股，换手率0.00%，振幅0.87%。机构评级方面，在所有11家参与评级的机构中，91%的券商给予买入建议，9%的券商给予持有建议，无券商给予卖出建议。再鼎医药股票所在的生物技术行业中，整体涨幅为0.00%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502282230259896793b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502282230259896793b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4548","ZLAB","BK4139","BK4585","BK4531","BK4526","BK4588"],"gpt_icon":0},{"id":"1150403075","title":"异动解读 | 再鼎医药盘前飙涨5.5%,原因是公司2024财年收入及新品获重大进展","url":"https://stock-news.laohu8.com/highlight/detail?id=1150403075","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150403075?lang=zh_cn&edition=fundamental","pubTime":"2025-02-27 21:02","pubTimestamp":1740661349,"startTime":"0","endTime":"0","summary":"再鼎医药(纳斯达克代码:ZLAB)27日盘前大涨5.5%,引发市场广泛关注。\n\n从公司最新财报来看,再鼎医药2024财年总收入达到3.99亿美元,同比增长50%,业绩持续向好是推动其股价上涨的重要原因。其核心产品卫伟迦和卫力迦2024年销售收入更是达到9360万美元,产品收入呈现强劲增长势头。\n\n此外,公司研发管线取得重大进展,也推升了投资者对其长期成长前景的信心。具有潜力成为同类首创且同类最佳药物的ZL-1310 (DLL3 ADC)用于治疗小细胞肺癌临床试验取得令人振奋的结果,ORR高达74%。同时公司的另一创新药物KarXT用于治疗精神分裂症的新药申请也已获NMPA受理。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ZLAB"],"gpt_icon":0},{"id":"2514406388","title":"再鼎医药公布2024年第四季度及全年财务业绩和近期公司进展","url":"https://stock-news.laohu8.com/highlight/detail?id=2514406388","media":"美通社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514406388?lang=zh_cn&edition=fundamental","pubTime":"2025-02-27 21:01","pubTimestamp":1740661260,"startTime":"0","endTime":"0","summary":"2024年第四季度总收入为1.091亿美元，同比增长66%。\" 再鼎医药总裁兼首席运营官Josh Smiley表示：\"2024年第四季度和全年总收入分别增长了66%和50%，这主要是由于艾加莫德持续的强劲表现以及则乐和纽再乐销售收入的持续增长。卫伟迦和卫力迦2024 年第四季度产品收入净额为 3,000 万美元，2023 年同期为 510 万美元；2024 年全年的产品收入净额为 9,360 万美元， 2023 年同期为1,000 万美元。2024 年第四季度的销售、一般及行政  开支为 8,260 万美元，与 2023 年同期持平。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4629093_ZH29093_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["BK4139","09688","BK1161","BK1574","BK4588","BK4526","BK4531","BK4548","ZLAB","BK4585","BK1588","LU2488822045.USD"],"gpt_icon":0},{"id":"2514969801","title":"再鼎医药2024年年报：经营亏损降至2.82亿美元 同比下降23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514969801","media":"财中社","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514969801?lang=zh_cn&edition=fundamental","pubTime":"2025-02-27 20:43","pubTimestamp":1740660233,"startTime":"0","endTime":"0","summary":"2月27日，再鼎医药（09688/ZLAB）发布截至2024年12月31日止年度的财务业绩及近期公司进展。2024年第四季度总收入为1.09亿美元，同比增长66%；全年总收入为3.99亿美元，同比增长50%。公司的全年收入指引预计在5.6亿美元至5.9亿美元之间。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202502273331934047.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4531","BK4585","BK1588","09688","BK1161","BK4526","BK1574","BK4548","BK4139","LU2488822045.USD","ZLAB","BK4588"],"gpt_icon":0}],"pageSize":20,"totalPage":12,"pageCount":4,"totalSize":226,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ZLAB\",params:#limit:5,,,undefined,":[{"date":"2025-05-08","symbol":"ZLAB","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2025/03","expectedEps":-0.33,"defaultRemindTime":1746691200000,"name":null,"time":"盘前","dateTimestamp":1746676800000,"actualEps":null},{"market":"US","date":"2025-02-27","symbol":"ZLAB","fiscalQuarterEnding":"2024/12","expectedEps":-0.61,"name":null,"time":"盘前","type":"earning","dateTimestamp":1740632400000,"reportTimeType":"pre","actualEps":-0.8},{"market":"US","date":"2024-11-12","symbol":"ZLAB","fiscalQuarterEnding":"2024/09","expectedEps":-0.75,"name":null,"time":"盘前","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"pre","actualEps":-0.42},{"market":"US","date":"2024-08-06","symbol":"ZLAB","fiscalQuarterEnding":"2024/06","expectedEps":-0.66,"name":null,"time":"盘后","type":"earning","dateTimestamp":1722916800000,"reportTimeType":"post","actualEps":-0.82},{"market":"US","date":"2024-05-08","symbol":"ZLAB","fiscalQuarterEnding":"2024/03","expectedEps":-0.93,"name":null,"time":"盘后","type":"earning","dateTimestamp":1715140800000,"reportTimeType":"post","actualEps":-0.55}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ZLAB\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ZLAB\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.25,"buy":0.6667,"hold":0.0833,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":12,"updateTime":1741320000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ZLAB\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ZLAB","date":"2025-04-17","current":-12.338833,"percent":0.360908,"low":-70.191885,"twenty":-29.186349,"median":-8.758169,"eighty":-6.018033,"high":-3.497954,"avg":-16.407627,"sd":14.72872,"marketCap":3172351050},"quantilePoints":[{"date":"2020-04-24","current":-24.094259,"twenty":-23.592647,"median":-18.880149,"eighty":-14.130821,"marketCap":4700091172},{"date":"2020-05-01","current":-23.129498,"twenty":-23.613177,"median":-18.914701,"eighty":-14.139912,"marketCap":4511894374},{"date":"2020-05-08","current":-25.257933,"twenty":-23.662459,"median":-18.938355,"eighty":-14.150617,"marketCap":4927090215},{"date":"2020-05-15","current":-26.900196,"twenty":-23.726253,"median":-19.009638,"eighty":-14.152817,"marketCap":5247448157},{"date":"2020-05-22","current":-24.308559,"twenty":-23.788888,"median":-19.207405,"eighty":-14.153961,"marketCap":4741894948},{"date":"2020-05-29","current":-28.481209,"twenty":-23.839084,"median":-19.326207,"eighty":-14.163726,"marketCap":5555858018},{"date":"2020-06-05","current":-26.842774,"twenty":-23.893243,"median":-19.364645,"eighty":-14.171547,"marketCap":5236246831},{"date":"2020-06-12","current":-26.414025,"twenty":-23.999823,"median":-19.43601,"eighty":-14.176941,"marketCap":5152610259},{"date":"2020-06-19","current":-30.950347,"twenty":-24.056732,"median":-19.476275,"eighty":-14.184311,"marketCap":6037515064},{"date":"2020-06-26","current":-31.00394,"twenty":-24.157929,"median":-19.537425,"eighty":-14.187273,"marketCap":6047969635},{"date":"2020-07-02","current":-31.04605,"twenty":-24.202294,"median":-19.552614,"eighty":-14.201881,"marketCap":6056183942},{"date":"2020-07-10","current":-33.293156,"twenty":-24.250079,"median":-19.576593,"eighty":-14.225256,"marketCap":6494529191},{"date":"2020-07-17","current":-32.026048,"twenty":-24.284615,"median":-19.579643,"eighty":-14.23038,"marketCap":6247353250},{"date":"2020-07-24","current":-29.101365,"twenty":-24.419828,"median":-19.661033,"eighty":-14.240629,"marketCap":5676832346},{"date":"2020-07-31","current":-29.135818,"twenty":-24.543035,"median":-19.733573,"eighty":-14.249414,"marketCap":5683553142},{"date":"2020-08-07","current":-30.758941,"twenty":-24.568219,"median":-19.896124,"eighty":-14.259663,"marketCap":6000177308},{"date":"2020-08-14","current":-24.771404,"twenty":-24.655095,"median":-19.930417,"eighty":-14.284724,"marketCap":5955392341},{"date":"2020-08-21","current":-25.033041,"twenty":-24.76236,"median":-19.986027,"eighty":-14.304209,"marketCap":6018293505},{"date":"2020-08-28","current":-25.363202,"twenty":-24.8202,"median":-20.114624,"eighty":-14.316062,"marketCap":6097668783},{"date":"2020-09-04","current":-24.266819,"twenty":-24.825574,"median":-20.18363,"eighty":-14.332915,"marketCap":5834082953},{"date":"2020-09-11","current":-23.413384,"twenty":-24.822887,"median":-20.250412,"eighty":-14.359222,"marketCap":5628905347},{"date":"2020-09-18","current":-24.690421,"twenty":-24.825574,"median":-20.370961,"eighty":-14.406805,"marketCap":5935922933},{"date":"2020-09-25","current":-28.194955,"twenty":-24.942257,"median":-20.389609,"eighty":-14.430231,"marketCap":6778461960},{"date":"2020-10-02","current":-30.220081,"twenty":-24.988766,"median":-20.432368,"eighty":-14.468298,"marketCap":7265330486},{"date":"2020-10-09","current":-34.050625,"twenty":-25.027727,"median":-20.466816,"eighty":-14.484724,"marketCap":8186246973},{"date":"2020-10-16","current":-33.113318,"twenty":-25.093809,"median":-20.570159,"eighty":-14.504719,"marketCap":7960905120},{"date":"2020-10-23","current":-31.927038,"twenty":-25.243468,"median":-20.624567,"eighty":-14.515149,"marketCap":7675706839},{"date":"2020-10-30","current":-30.041439,"twenty":-25.323065,"median":-20.665008,"eighty":-14.544118,"marketCap":7222382410},{"date":"2020-11-06","current":-32.238253,"twenty":-25.42744,"median":-20.707949,"eighty":-14.566603,"marketCap":7750527376},{"date":"2020-11-13","current":-37.89505,"twenty":-25.519829,"median":-20.767002,"eighty":-14.570989,"marketCap":9110500663},{"date":"2020-11-20","current":-38.19162,"twenty":-25.697643,"median":-20.8758,"eighty":-14.58524,"marketCap":9181800233},{"date":"2020-11-27","current":-39.59392,"twenty":-25.816838,"median":-20.916026,"eighty":-14.592132,"marketCap":9518932770},{"date":"2020-12-04","current":-39.542661,"twenty":-25.973516,"median":-21.013057,"eighty":-14.597139,"marketCap":9506609388},{"date":"2020-12-11","current":-39.861199,"twenty":-26.169025,"median":-21.051581,"eighty":-14.600746,"marketCap":9583190408},{"date":"2020-12-18","current":-45.858503,"twenty":-26.377046,"median":-21.101637,"eighty":-14.635202,"marketCap":11025026165},{"date":"2020-12-24","current":-48.981641,"twenty":-26.418383,"median":-21.16069,"eighty":-14.662767,"marketCap":11775872258},{"date":"2020-12-31","current":-49.552813,"twenty":-26.481373,"median":-21.190463,"eighty":-14.681051,"marketCap":11913189949},{"date":"2021-01-08","current":-53.397238,"twenty":-26.562079,"median":-21.278796,"eighty":-14.715,"marketCap":12837443640},{"date":"2021-01-15","current":-62.5726,"twenty":-26.603416,"median":-21.337849,"eighty":-14.76718,"marketCap":15043329114},{"date":"2021-01-22","current":-66.548835,"twenty":-26.662469,"median":-21.349326,"eighty":-14.79207,"marketCap":15999271503},{"date":"2021-01-29","current":-58.60735,"twenty":-26.735301,"median":-21.409489,"eighty":-14.799869,"marketCap":14090027451},{"date":"2021-02-05","current":-64.996419,"twenty":-26.934719,"median":-21.457645,"eighty":-14.807482,"marketCap":15626049060},{"date":"2021-02-12","current":-66.845404,"twenty":-27.162982,"median":-21.509254,"eighty":-14.808263,"marketCap":16070571073},{"date":"2021-02-19","current":-64.205566,"twenty":-27.248757,"median":-21.5739,"eighty":-14.810143,"marketCap":15435916872},{"date":"2021-02-26","current":-54.012346,"twenty":-27.446117,"median":-21.618351,"eighty":-14.813598,"marketCap":12985324230},{"date":"2021-03-05","current":-45.217824,"twenty":-27.556139,"median":-21.70201,"eighty":-14.818424,"marketCap":12159299076},{"date":"2021-03-12","current":-47.339521,"twenty":-27.798707,"median":-21.751221,"eighty":-14.828854,"marketCap":12729833765},{"date":"2021-03-19","current":-43.643025,"twenty":-28.086913,"median":-21.792251,"eighty":-14.83677,"marketCap":11735827677},{"date":"2021-03-26","current":-42.308729,"twenty":-28.347225,"median":-21.864344,"eighty":-14.850652,"marketCap":11377028688},{"date":"2021-04-01","current":-43.145547,"twenty":-28.611221,"median":-21.939881,"eighty":-14.851052,"marketCap":11602053239},{"date":"2021-04-09","current":-43.695738,"twenty":-29.047771,"median":-21.986531,"eighty":-14.915582,"marketCap":11750002452},{"date":"2021-04-16","current":-54.492888,"twenty":-29.135818,"median":-22.004822,"eighty":-14.952185,"marketCap":14653410031},{"date":"2021-04-23","current":-61.084235,"twenty":-29.730354,"median":-22.065694,"eighty":-14.979571,"marketCap":16425856151},{"date":"2021-04-30","current":-58.66303,"twenty":-30.041439,"median":-22.085855,"eighty":-14.989091,"marketCap":15774782174},{"date":"2021-05-07","current":-55.814762,"twenty":-30.220081,"median":-22.141456,"eighty":-14.989091,"marketCap":15008868618},{"date":"2021-05-14","current":-31.982218,"twenty":-30.413112,"median":-22.163846,"eighty":-15.031446,"marketCap":14514394066},{"date":"2021-05-21","current":-34.454132,"twenty":-30.510113,"median":-22.19904,"eighty":-15.057288,"marketCap":15636215409},{"date":"2021-05-28","current":-37.153998,"twenty":-30.720659,"median":-22.235607,"eighty":-15.06525,"marketCap":16861487281},{"date":"2021-06-04","current":-35.859484,"twenty":-30.940846,"median":-22.265709,"eighty":-15.065572,"marketCap":16274002162},{"date":"2021-06-11","current":-35.474685,"twenty":-31.053706,"median":-22.299289,"eighty":-15.072743,"marketCap":16099370075},{"date":"2021-06-18","current":-32.896115,"twenty":-31.185177,"median":-22.396424,"eighty":-15.078527,"marketCap":14929145273},{"date":"2021-06-25","current":-36.327935,"twenty":-31.27996,"median":-22.457676,"eighty":-15.103567,"marketCap":16486597746},{"date":"2021-07-02","current":-36.785929,"twenty":-31.507732,"median":-22.499226,"eighty":-15.145417,"marketCap":16694447893},{"date":"2021-07-09","current":-35.342934,"twenty":-31.689452,"median":-22.596835,"eighty":-15.158144,"marketCap":16039577567},{"date":"2021-07-16","current":-32.77482,"twenty":-31.943673,"median":-22.634646,"eighty":-15.16295,"marketCap":14874098202},{"date":"2021-07-23","current":-31.369468,"twenty":-32.025956,"median":-22.65704,"eighty":-15.187765,"marketCap":14236311450},{"date":"2021-07-30","current":-30.242258,"twenty":-31.999688,"median":-22.697225,"eighty":-15.20872,"marketCap":13724753325},{"date":"2021-08-06","current":-31.14779,"twenty":-31.974063,"median":-22.75379,"eighty":-15.218763,"marketCap":14135708182},{"date":"2021-08-13","current":-26.716909,"twenty":-31.943673,"median":-22.82762,"eighty":-15.228327,"marketCap":14334209548},{"date":"2021-08-20","current":-23.85921,"twenty":-31.815,"median":-22.867756,"eighty":-15.243272,"marketCap":12800991048},{"date":"2021-08-27","current":-24.408699,"twenty":-31.728607,"median":-23.009723,"eighty":-15.273736,"marketCap":13095804064},{"date":"2021-09-03","current":-25.886451,"twenty":-31.708717,"median":-23.068439,"eighty":-15.308959,"marketCap":13888650718},{"date":"2021-09-10","current":-24.422925,"twenty":-31.693187,"median":-23.078473,"eighty":-15.326547,"marketCap":13103436763},{"date":"2021-09-17","current":-22.87582,"twenty":-31.646577,"median":-23.074273,"eighty":-15.334367,"marketCap":12273380699},{"date":"2021-09-24","current":-21.314488,"twenty":-31.562869,"median":-23.048961,"eighty":-15.336513,"marketCap":11435691935},{"date":"2021-10-01","current":-18.271848,"twenty":-31.512349,"median":-22.970142,"eighty":-15.338528,"marketCap":9803248343},{"date":"2021-10-08","current":-18.200717,"twenty":-31.49731,"median":-22.867756,"eighty":-15.343365,"marketCap":9765084846},{"date":"2021-10-15","current":-18.138477,"twenty":-31.467221,"median":-22.82762,"eighty":-15.3615,"marketCap":9731691786},{"date":"2021-10-22","current":-17.916191,"twenty":-31.417014,"median":-22.75379,"eighty":-15.391511,"marketCap":9612430857},{"date":"2021-10-29","current":-18.565264,"twenty":-31.376997,"median":-22.697225,"eighty":-15.403532,"marketCap":9960672769},{"date":"2021-11-05","current":-15.736018,"twenty":-31.357757,"median":-22.65704,"eighty":-15.406822,"marketCap":8442719668},{"date":"2021-11-12","current":-14.42592,"twenty":-31.305892,"median":-22.634646,"eighty":-15.3615,"marketCap":8211132641},{"date":"2021-11-19","current":-14.253154,"twenty":-31.249181,"median":-22.596835,"eighty":-15.338528,"marketCap":8112795723},{"date":"2021-11-26","current":-13.031939,"twenty":-31.240083,"median":-22.499226,"eighty":-15.324417,"marketCap":7417688686},{"date":"2021-12-03","current":-11.072237,"twenty":-31.229375,"median":-22.470522,"eighty":-15.224806,"marketCap":6302239529},{"date":"2021-12-10","current":-11.095949,"twenty":-31.200607,"median":-22.439494,"eighty":-15.161421,"marketCap":6315736753},{"date":"2021-12-17","current":-12.417097,"twenty":-31.174925,"median":-22.338924,"eighty":-15.075519,"marketCap":7067724949},{"date":"2021-12-23","current":-11.151844,"twenty":-31.154491,"median":-22.274203,"eighty":-15.057288,"marketCap":6347551639},{"date":"2021-12-31","current":-10.645404,"twenty":-31.14779,"median":-22.263014,"eighty":-14.979571,"marketCap":6059289497},{"date":"2022-01-07","current":-9.329337,"twenty":-31.114956,"median":-22.214671,"eighty":-14.851052,"marketCap":5310193564},{"date":"2022-01-14","current":-8.431634,"twenty":-31.084331,"median":-22.18229,"eighty":-14.816096,"marketCap":4799227226},{"date":"2022-01-21","current":-8.567137,"twenty":-31.053706,"median":-22.163846,"eighty":-14.807482,"marketCap":4876354220},{"date":"2022-01-28","current":-7.354391,"twenty":-31.012362,"median":-22.141456,"eighty":-14.723784,"marketCap":4186067621},{"date":"2022-02-04","current":-8.436716,"twenty":-30.980856,"median":-22.085855,"eighty":-14.628311,"marketCap":4802119488},{"date":"2022-02-11","current":-9.087127,"twenty":-30.955295,"median":-22.067325,"eighty":-14.580453,"marketCap":5172329061},{"date":"2022-02-18","current":-10.049194,"twenty":-30.940846,"median":-22.047481,"eighty":-14.555498,"marketCap":5719930722},{"date":"2022-02-25","current":-9.156572,"twenty":-30.885884,"median":-21.997275,"eighty":-14.49415,"marketCap":5211856646},{"date":"2022-03-04","current":-5.542533,"twenty":-30.839706,"median":-21.962552,"eighty":-14.42413,"marketCap":3904554091},{"date":"2022-03-11","current":-4.075473,"twenty":-30.788281,"median":-21.908695,"eighty":-14.318274,"marketCap":2871052366},{"date":"2022-03-18","current":-5.300304,"twenty":-30.737531,"median":-21.805352,"eighty":-14.251658,"marketCap":3733910616},{"date":"2022-03-25","current":-5.790237,"twenty":-30.721698,"median":-21.751221,"eighty":-14.225988,"marketCap":4079053916},{"date":"2022-04-01","current":-6.222691,"twenty":-30.674722,"median":-21.721694,"eighty":-14.176941,"marketCap":4383705544},{"date":"2022-04-08","current":-5.95446,"twenty":-30.632612,"median":-21.652799,"eighty":-14.152817,"marketCap":4194744407},{"date":"2022-04-14","current":-6.077627,"twenty":-30.622584,"median":-21.61343,"eighty":-14.127893,"marketCap":4281512276},{"date":"2022-04-22","current":-5.938038,"twenty":-30.575461,"median":-21.538781,"eighty":-14.029798,"marketCap":4183175358},{"date":"2022-04-29","current":-5.468633,"twenty":-30.502457,"median":-21.494095,"eighty":-13.794645,"marketCap":3852493370},{"date":"2022-05-06","current":-3.907144,"twenty":-30.490972,"median":-21.4568,"eighty":-13.63009,"marketCap":2752469612},{"date":"2022-05-13","current":-5.869804,"twenty":-30.470956,"median":-21.382707,"eighty":-13.528661,"marketCap":3251607517},{"date":"2022-05-20","current":-6.500605,"twenty":-30.429804,"median":-21.348509,"eighty":-13.43743,"marketCap":3601042762},{"date":"2022-05-27","current":-5.283177,"twenty":-30.389182,"median":-21.314488,"eighty":-13.321203,"marketCap":2926642527},{"date":"2022-06-03","current":-5.369758,"twenty":-30.344466,"median":-21.288638,"eighty":-13.271436,"marketCap":2974604228},{"date":"2022-06-10","current":-4.701851,"twenty":-30.304222,"median":-21.227641,"eighty":-13.24314,"marketCap":2604613968},{"date":"2022-06-17","current":-4.899749,"twenty":-30.276534,"median":-21.170532,"eighty":-13.175833,"marketCap":2714240712},{"date":"2022-06-24","current":-6.046499,"twenty":-30.245103,"median":-21.150159,"eighty":-13.093294,"marketCap":3349488538},{"date":"2022-07-01","current":-6.809821,"twenty":-30.242258,"median":-21.086643,"eighty":-13.023225,"marketCap":3772334549},{"date":"2022-07-08","current":-6.802753,"twenty":-30.224516,"median":-21.036962,"eighty":-12.958495,"marketCap":3768419308},{"date":"2022-07-15","current":-6.891101,"twenty":-30.142795,"median":-21.013057,"eighty":-12.86933,"marketCap":3817359819},{"date":"2022-07-22","current":-7.751605,"twenty":-30.092848,"median":-20.916026,"eighty":-12.799623,"marketCap":4294040391},{"date":"2022-07-29","current":-7.161444,"twenty":-30.051504,"median":-20.856649,"eighty":-12.745999,"marketCap":3967117781},{"date":"2022-08-05","current":-7.998978,"twenty":-30.041768,"median":-20.752239,"eighty":-12.585051,"marketCap":4431073820},{"date":"2022-08-12","current":-8.009762,"twenty":-30.012129,"median":-20.688265,"eighty":-12.56106,"marketCap":4233671664},{"date":"2022-08-19","current":-7.764953,"twenty":-30.001891,"median":-20.661245,"eighty":-12.531454,"marketCap":4104274862},{"date":"2022-08-26","current":-8.44679,"twenty":-29.973449,"median":-20.61008,"eighty":-12.48663,"marketCap":4464668918},{"date":"2022-09-02","current":-8.379694,"twenty":-29.855849,"median":-20.520948,"eighty":-12.46877,"marketCap":4429204609},{"date":"2022-09-09","current":-8.849363,"twenty":-29.769485,"median":-20.466816,"eighty":-12.403219,"marketCap":4677454770},{"date":"2022-09-16","current":-8.604555,"twenty":-29.633839,"median":-20.432368,"eighty":-12.365391,"marketCap":4548057968},{"date":"2022-09-23","current":-6.709558,"twenty":-29.541612,"median":-20.373315,"eighty":-12.302576,"marketCap":3546430871},{"date":"2022-09-30","current":-6.201808,"twenty":-29.541612,"median":-20.203241,"eighty":-12.191623,"marketCap":3278052318},{"date":"2022-10-07","current":-5.989641,"twenty":-29.541612,"median":-20.108374,"eighty":-12.15671,"marketCap":3165908423},{"date":"2022-10-14","current":-5.209881,"twenty":-29.096771,"median":-19.930417,"eighty":-12.052529,"marketCap":2753755646},{"date":"2022-10-21","current":-5.202628,"twenty":-29.015615,"median":-19.733573,"eighty":-11.930786,"marketCap":2749921667},{"date":"2022-10-28","current":-4.306811,"twenty":-29.015615,"median":-19.579643,"eighty":-11.900256,"marketCap":2276425221},{"date":"2022-11-04","current":-5.608828,"twenty":-29.015615,"median":-19.552614,"eighty":-11.829037,"marketCap":2964624509},{"date":"2022-11-11","current":-6.107643,"twenty":-29.015615,"median":-19.467661,"eighty":-11.731599,"marketCap":3623921373},{"date":"2022-11-18","current":-5.654746,"twenty":-29.015615,"median":-19.351354,"eighty":-11.664535,"marketCap":3355198390},{"date":"2022-11-25","current":-5.130679,"twenty":-29.015615,"median":-19.207405,"eighty":-11.590681,"marketCap":3044247509},{"date":"2022-12-02","current":-5.918397,"twenty":-29.015615,"median":-18.95082,"eighty":-11.447489,"marketCap":3511633555},{"date":"2022-12-09","current":-5.725916,"twenty":-29.015615,"median":-18.906907,"eighty":-11.206363,"marketCap":3397426287},{"date":"2022-12-16","current":-5.271401,"twenty":-29.015615,"median":-18.733699,"eighty":-11.091207,"marketCap":3127743579},{"date":"2022-12-23","current":-4.978635,"twenty":-29.015615,"median":-18.671961,"eighty":-10.906336,"marketCap":2954033365},{"date":"2022-12-30","current":-4.965695,"twenty":-29.015615,"median":-18.565264,"eighty":-10.634564,"marketCap":2946355565},{"date":"2023-01-06","current":-7.493833,"twenty":-29.015615,"median":-18.52792,"eighty":-9.950277,"marketCap":4446405647},{"date":"2023-01-13","current":-7.702489,"twenty":-29.015615,"median":-18.405811,"eighty":-9.574597,"marketCap":4570210164},{"date":"2023-01-20","current":-7.364433,"twenty":-29.015615,"median":-18.314527,"eighty":-9.317142,"marketCap":4369627651},{"date":"2023-01-27","current":-7.259297,"twenty":-29.015615,"median":-18.246322,"eighty":-9.156572,"marketCap":4307245530},{"date":"2023-02-03","current":-6.484519,"twenty":-29.015615,"median":-18.200717,"eighty":-9.047235,"marketCap":3847537284},{"date":"2023-02-10","current":-6.122201,"twenty":-29.015615,"median":-18.119456,"eighty":-8.886031,"marketCap":3632558897},{"date":"2023-02-17","current":-6.046179,"twenty":-29.015615,"median":-18.057826,"eighty":-8.759327,"marketCap":3587451825},{"date":"2023-02-24","current":-5.751796,"twenty":-29.015615,"median":-17.921222,"eighty":-8.583397,"marketCap":3412781886},{"date":"2023-03-03","current":-8.861679,"twenty":-29.015615,"median":-17.733028,"eighty":-8.443152,"marketCap":3928258260},{"date":"2023-03-10","current":-7.078946,"twenty":-29.015615,"median":-17.620519,"eighty":-8.424182,"marketCap":3137997554},{"date":"2023-03-17","current":-7.332384,"twenty":-29.015615,"median":-17.516231,"eighty":-8.370794,"marketCap":3250343244},{"date":"2023-03-24","current":-6.866664,"twenty":-29.015615,"median":-17.307188,"eighty":-8.236436,"marketCap":3043896036},{"date":"2023-03-31","current":-7.204582,"twenty":-29.004897,"median":-17.276248,"eighty":-8.075956,"marketCap":3193690289},{"date":"2023-04-06","current":-7.176422,"twenty":-29.004897,"median":-17.202891,"eighty":-7.989892,"marketCap":3181207435},{"date":"2023-04-14","current":-8.593078,"twenty":-29.015615,"median":-17.06919,"eighty":-7.891662,"marketCap":3809191034},{"date":"2023-04-21","current":-7.984464,"twenty":-29.015615,"median":-16.99544,"eighty":-7.891662,"marketCap":3539401059},{"date":"2023-04-28","current":-7.776846,"twenty":-29.015615,"median":-16.859752,"eighty":-7.860701,"marketCap":3447366841},{"date":"2023-05-05","current":-7.80335,"twenty":-29.015615,"median":-16.711178,"eighty":-7.779136,"marketCap":3459115890},{"date":"2023-05-12","current":-8.758481,"twenty":-29.015615,"median":-16.556126,"eighty":-7.779136,"marketCap":3591292693},{"date":"2023-05-19","current":-7.514433,"twenty":-29.015615,"median":-16.512276,"eighty":-7.777327,"marketCap":3081188142},{"date":"2023-05-26","current":-7.600394,"twenty":-29.015615,"median":-16.188599,"eighty":-7.760884,"marketCap":3116435289},{"date":"2023-06-02","current":-7.879768,"twenty":-29.015615,"median":-16.07912,"eighty":-7.741381,"marketCap":3230988519},{"date":"2023-06-09","current":-6.695415,"twenty":-29.015615,"median":-15.931561,"eighty":-7.695125,"marketCap":2745361153},{"date":"2023-06-16","current":-6.831418,"twenty":-29.015615,"median":-15.828905,"eighty":-7.646159,"marketCap":2801127513},{"date":"2023-06-23","current":-6.236339,"twenty":-29.026334,"median":-15.755613,"eighty":-7.608914,"marketCap":2557123430},{"date":"2023-06-30","current":-6.346717,"twenty":-29.037052,"median":-15.600052,"eighty":-7.515866,"marketCap":2602382252},{"date":"2023-07-07","current":-6.728239,"twenty":-29.037052,"median":-15.522205,"eighty":-7.438591,"marketCap":2758820353},{"date":"2023-07-14","current":-6.831418,"twenty":-29.037052,"median":-15.415087,"eighty":-7.364757,"marketCap":2801127513},{"date":"2023-07-21","current":-6.905803,"twenty":-29.037052,"median":-15.359192,"eighty":-7.336328,"marketCap":2831628023},{"date":"2023-07-28","current":-7.174549,"twenty":-29.037052,"median":-15.332936,"eighty":-7.319592,"marketCap":2941823415},{"date":"2023-08-04","current":-6.670651,"twenty":-29.037052,"median":-15.223045,"eighty":-7.267708,"marketCap":2735207055},{"date":"2023-08-11","current":-6.442226,"twenty":-29.037052,"median":-15.154377,"eighty":-7.204582,"marketCap":2531782075},{"date":"2023-08-18","current":-5.854067,"twenty":-29.037052,"median":-15.06525,"eighty":-7.188963,"marketCap":2300636470},{"date":"2023-08-25","current":-6.056794,"twenty":-29.037052,"median":-14.979571,"eighty":-7.130627,"marketCap":2380307934},{"date":"2023-09-01","current":-6.374651,"twenty":-29.037052,"median":-14.850552,"eighty":-7.070882,"marketCap":2505224921},{"date":"2023-09-08","current":-6.840173,"twenty":-29.037052,"median":-14.812973,"eighty":-7.040785,"marketCap":2688174208},{"date":"2023-09-15","current":-6.402181,"twenty":-29.037052,"median":-14.790254,"eighty":-6.935117,"marketCap":2516044502},{"date":"2023-09-22","current":-6.001732,"twenty":-29.037052,"median":-14.635202,"eighty":-6.903404,"marketCap":2358668771},{"date":"2023-09-29","current":-6.006738,"twenty":-29.037052,"median":-14.568197,"eighty":-6.867311,"marketCap":2360635968},{"date":"2023-10-06","current":-5.791496,"twenty":-29.037052,"median":-14.509293,"eighty":-6.836446,"marketCap":2276046512},{"date":"2023-10-13","current":-5.90162,"twenty":-29.037052,"median":-14.480011,"eighty":-6.818542,"marketCap":2319324838},{"date":"2023-10-20","current":-5.8841,"twenty":-29.037052,"median":-14.46537,"eighty":-6.800731,"marketCap":2312439650},{"date":"2023-10-27","current":-5.748949,"twenty":-29.066146,"median":-14.491793,"eighty":-6.792505,"marketCap":2259325341},{"date":"2023-11-03","current":-6.377153,"twenty":-29.066146,"median":-14.448186,"eighty":-6.726571,"marketCap":2506208519},{"date":"2023-11-10","current":-9.202286,"twenty":-29.066146,"median":-14.335469,"eighty":-6.723357,"marketCap":2769519948},{"date":"2023-11-17","current":-8.627143,"twenty":-29.066146,"median":-14.251284,"eighty":-6.723357,"marketCap":2596424952},{"date":"2023-11-24","current":-9.270911,"twenty":-29.066146,"median":-14.225622,"eighty":-6.723357,"marketCap":2790173329},{"date":"2023-12-01","current":-8.917982,"twenty":-29.066146,"median":-14.137052,"eighty":-6.723357,"marketCap":2683955944},{"date":"2023-12-08","current":-8.986607,"twenty":-29.056959,"median":-13.963913,"eighty":-6.723713,"marketCap":2704609325},{"date":"2023-12-15","current":-9.872197,"twenty":-29.056959,"median":-13.565865,"eighty":-6.723713,"marketCap":2971136280},{"date":"2023-12-22","current":-8.496429,"twenty":-29.056959,"median":-13.418306,"eighty":-6.723713,"marketCap":2557085180},{"date":"2023-12-29","current":-8.917982,"twenty":-29.066146,"median":-13.323107,"eighty":-6.723357,"marketCap":2683955944},{"date":"2024-01-05","current":-8.689232,"twenty":-29.075334,"median":-13.259367,"eighty":-6.723002,"marketCap":2615111343},{"date":"2024-01-12","current":-8.238268,"twenty":-29.075334,"median":-13.209015,"eighty":-6.723002,"marketCap":2479389130},{"date":"2024-01-19","current":-7.699072,"twenty":-29.084521,"median":-13.098684,"eighty":-6.722646,"marketCap":2317112570},{"date":"2024-01-26","current":-7.554188,"twenty":-29.075334,"median":-13.020195,"eighty":-6.723002,"marketCap":2273508472},{"date":"2024-02-02","current":-7.38362,"twenty":-29.075334,"median":-12.875672,"eighty":-6.723002,"marketCap":2222174369},{"date":"2024-02-09","current":-6.430736,"twenty":-29.075334,"median":-12.781023,"eighty":-6.720725,"marketCap":1935394425},{"date":"2024-02-16","current":-6.524221,"twenty":-29.075334,"median":-12.697103,"eighty":-6.671897,"marketCap":1963529462},{"date":"2024-02-23","current":-6.586544,"twenty":-29.075334,"median":-12.576673,"eighty":-6.654044,"marketCap":1982286154},{"date":"2024-03-01","current":-6.18939,"twenty":-29.066146,"median":-12.543601,"eighty":-6.637041,"marketCap":2071093632},{"date":"2024-03-08","current":-5.652465,"twenty":-29.066146,"median":-12.498566,"eighty":-6.617923,"marketCap":1891427740},{"date":"2024-03-15","current":-5.76752,"twenty":-29.066146,"median":-12.498566,"eighty":-6.583974,"marketCap":1929927574},{"date":"2024-03-22","current":-5.088988,"twenty":-29.066146,"median":-12.475261,"eighty":-6.542776,"marketCap":1702877271},{"date":"2024-03-28","current":-4.776274,"twenty":-29.066146,"median":-12.475261,"eighty":-6.532757,"marketCap":1598236697},{"date":"2024-04-05","current":-4.557963,"twenty":-29.075334,"median":-12.426602,"eighty":-6.487946,"marketCap":1525185730},{"date":"2024-04-12","current":-4.428157,"twenty":-29.075334,"median":-12.361423,"eighty":-6.444228,"marketCap":1481750020},{"date":"2024-04-19","current":-4.195096,"twenty":-29.075334,"median":-12.264657,"eighty":-6.431272,"marketCap":1403763177},{"date":"2024-04-26","current":-4.643517,"twenty":-29.066146,"median":-12.216137,"eighty":-6.393478,"marketCap":1553813812},{"date":"2024-05-03","current":-4.894279,"twenty":-29.066146,"median":-12.192345,"eighty":-6.357979,"marketCap":1637723706},{"date":"2024-05-10","current":-6.149562,"twenty":-29.066146,"median":-12.146591,"eighty":-6.335607,"marketCap":2084375690},{"date":"2024-05-17","current":-5.83345,"twenty":-29.066146,"median":-11.977205,"eighty":-6.309891,"marketCap":1977230247},{"date":"2024-05-24","current":-5.578803,"twenty":-29.066146,"median":-11.899524,"eighty":-6.273912,"marketCap":1890918641},{"date":"2024-05-31","current":-5.324157,"twenty":-29.066146,"median":-11.769584,"eighty":-6.2445,"marketCap":1804607035},{"date":"2024-06-07","current":-5.561241,"twenty":-29.066146,"median":-11.652456,"eighty":-6.233069,"marketCap":1884966117},{"date":"2024-06-14","current":-5.763202,"twenty":-29.075334,"median":-11.398067,"eighty":-6.212205,"marketCap":1953420149},{"date":"2024-06-21","current":-5.268545,"twenty":-29.084521,"median":-11.198583,"eighty":-6.188557,"marketCap":1785757374},{"date":"2024-06-28","current":-5.123336,"twenty":-29.096771,"median":-11.095949,"eighty":-6.180047,"marketCap":1736539423},{"date":"2024-07-05","current":-5.035608,"twenty":-29.096771,"median":-10.90794,"eighty":-6.147577,"marketCap":1706804159},{"date":"2024-07-12","current":-5.216913,"twenty":-29.096771,"median":-10.618304,"eighty":-6.126141,"marketCap":1768257038},{"date":"2024-07-15","current":-5.275399,"twenty":-29.096771,"median":-10.094926,"eighty":-6.123502,"marketCap":1788080547},{"date":"2024-08-02","current":-5.39237,"twenty":-29.135818,"median":-9.803572,"eighty":-6.104809,"marketCap":1827727566},{"date":"2024-08-09","current":-5.731182,"twenty":-29.135818,"median":-9.624055,"eighty":-6.088906,"marketCap":1709777685},{"date":"2024-08-16","current":-5.477268,"twenty":-29.135818,"median":-9.343735,"eighty":-6.056794,"marketCap":1634027903},{"date":"2024-08-23","current":-5.773337,"twenty":-29.135818,"median":-9.263041,"eighty":-6.024182,"marketCap":1722353735},{"date":"2024-08-30","current":-6.431267,"twenty":-29.135818,"median":-9.197214,"eighty":-6.018781,"marketCap":1918633363},{"date":"2024-09-06","current":-6.460874,"twenty":-29.135818,"median":-9.156572,"eighty":-6.018781,"marketCap":1927465946},{"date":"2024-09-13","current":-6.77997,"twenty":-29.135818,"median":-9.067433,"eighty":-6.018781,"marketCap":2022661566},{"date":"2024-09-20","current":-6.937873,"twenty":-29.135818,"median":-8.986607,"eighty":-6.018781,"marketCap":2069768677},{"date":"2024-09-27","current":-7.43461,"twenty":-29.135818,"median":-8.917982,"eighty":-6.018781,"marketCap":2217959796},{"date":"2024-10-04","current":-8.099119,"twenty":-29.135818,"median":-8.895729,"eighty":-6.018781,"marketCap":2416202220},{"date":"2024-10-11","current":-8.332685,"twenty":-29.135818,"median":-8.845446,"eighty":-6.018781,"marketCap":2485881488},{"date":"2024-10-18","current":-8.671519,"twenty":-29.135818,"median":-8.76312,"eighty":-6.018781,"marketCap":2586965497},{"date":"2024-10-25","current":-10.91506,"twenty":-29.135818,"median":-8.76312,"eighty":-6.018781,"marketCap":3256279028},{"date":"2024-10-31","current":-10.145282,"twenty":-29.135818,"median":-8.76312,"eighty":-6.018781,"marketCap":3026631863},{"date":"2024-11-08","current":-10.135413,"twenty":-29.161084,"median":-8.758481,"eighty":-6.018407,"marketCap":3023687669},{"date":"2024-11-15","current":-9.692809,"twenty":-29.161084,"median":-8.758481,"eighty":-6.018407,"marketCap":2625277905},{"date":"2024-11-22","current":-9.340277,"twenty":-29.161084,"median":-8.758481,"eighty":-6.018407,"marketCap":2529795356},{"date":"2024-11-29","current":-10.485097,"twenty":-29.161084,"median":-8.758481,"eighty":-6.018407,"marketCap":2839867550},{"date":"2024-12-06","current":-10.176177,"twenty":-29.161084,"median":-8.758481,"eighty":-6.018407,"marketCap":2756197276},{"date":"2024-12-13","current":-10.668068,"twenty":-29.161084,"median":-8.758481,"eighty":-6.018407,"marketCap":2889424754},{"date":"2024-12-20","current":-10.468441,"twenty":-29.161084,"median":-8.758481,"eighty":-6.018407,"marketCap":2835356177},{"date":"2024-12-27","current":-10.867695,"twenty":-29.161084,"median":-8.758481,"eighty":-6.018407,"marketCap":2943493331},{"date":"2025-01-03","current":-9.905492,"twenty":-29.161084,"median":-8.758481,"eighty":-6.018407,"marketCap":2682882790},{"date":"2025-01-10","current":-9.701873,"twenty":-29.186349,"median":-8.758169,"eighty":-6.018033,"marketCap":2627732842},{"date":"2025-01-17","current":-10.133067,"twenty":-29.186349,"median":-8.758169,"eighty":-6.018033,"marketCap":2744520968},{"date":"2025-01-24","current":-10.312606,"twenty":-29.186349,"median":-8.758169,"eighty":-6.018033,"marketCap":2793148628},{"date":"2025-01-31","current":-11.197463,"twenty":-29.186349,"median":-8.758169,"eighty":-6.018033,"marketCap":3032810367},{"date":"2025-02-07","current":-11.185396,"twenty":-29.186349,"median":-8.758169,"eighty":-6.018033,"marketCap":3029542252},{"date":"2025-02-14","current":-11.591626,"twenty":-29.186349,"median":-8.758169,"eighty":-6.018033,"marketCap":3139568778},{"date":"2025-02-21","current":-12.464417,"twenty":-29.186349,"median":-8.758169,"eighty":-6.018033,"marketCap":3375962402},{"date":"2025-02-28","current":-14.567155,"twenty":-29.186349,"median":-8.758169,"eighty":-6.018033,"marketCap":3745259354},{"date":"2025-03-07","current":-14.80894,"twenty":-29.211615,"median":-8.757857,"eighty":-6.017658,"marketCap":3807422816},{"date":"2025-03-14","current":-15.122777,"twenty":-29.211615,"median":-8.757857,"eighty":-6.017658,"marketCap":3888111347},{"date":"2025-03-21","current":-15.620732,"twenty":-29.211615,"median":-8.757857,"eighty":-6.017658,"marketCap":4016137149},{"date":"2025-03-28","current":-15.139515,"twenty":-29.211615,"median":-8.757857,"eighty":-6.017658,"marketCap":3892414735},{"date":"2025-04-04","current":-15.574467,"twenty":-29.211615,"median":-8.757857,"eighty":-6.017658,"marketCap":4004242180},{"date":"2025-04-11","current":-10.32355,"twenty":-29.186349,"median":-8.758169,"eighty":-6.018033,"marketCap":2654215585},{"date":"2025-04-17","current":-12.338833,"twenty":-29.186349,"median":-8.758169,"eighty":-6.018033,"marketCap":3172351050}],"updateTime":1745260728745}}}